Status:
COMPLETED
Liposomal Based Intranasal Influenza Vaccine:Safety and Efficacy
Lead Sponsor:
Hadassah Medical Organization
Conditions:
Influenza
Eligibility:
All Genders
20-95 years
Phase:
PHASE1
PHASE2
Brief Summary
Influnza vaccination is highly recommended over the age of 50,but is only 50% efficatious among the elderly. A Vaccine given as a nasal spray may improve compliance and local immunity.Liposomes are li...
Eligibility Criteria
Inclusion
- Healthy young(20-45years old) and elderly(65-95 years old) volunteers -
Exclusion
- Known allergy to eggs and to the flu vaccine, pregnant and breast feeding women, chronic viral carriers, recently hospitalized persons
- \-
Key Trial Info
Start Date :
October 1 2005
Trial Type :
INTERVENTIONAL
End Date :
April 1 2006
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00197301
Start Date
October 1 2005
End Date
April 1 2006
Last Update
November 7 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hadassah Medical Organization
Jerusalem, Israel, 91120